Moderna, Inc.: Moderna Receives Refusal-to-File Letter from the U.S. Food and Drug Administration for Its Investigational Seasonal Influenza Vaccine, mRNA-1010

Refusal to review the submission is inconsistent with feedback at pre-Phase 3 and pre-submission consultations; Moderna has requested a Type A meeting to understand the path forwardmRNA-1010 has been ...
27East

Southampton Village Releases Draft Historic District Registration Form

Following a Freedom of Information Law request by The Southampton Press in November 2025 and the issuance of an advisory opinion by the New York State Committee on Open Government ...